MWM
EW icon

Mosley Wealth Management’s Edwards Lifesciences EW Stock Holding History

Mosley Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.24K Buy
69
+1
+1% +$84 ﹤0.01% 416
2026
Q1 		$5.29K Buy
+68
New +$5.61K ﹤0.01% 337

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Mosley Wealth Management's EW Position: Q2 2026 in Review

Mosley Wealth Management increased its Edwards Lifesciences (EW) stake by 1.5% in Q2 2026, buying an estimated $84 and bringing the position to 69 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Mosley Wealth Management first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mosley Wealth Management held 69 shares of Edwards Lifesciences worth $6.24K as of Q2 2026.
  • Mosley Wealth Management bought 1 Edwards Lifesciences share in Q2 2026, an estimated $84.
  • Edwards Lifesciences made up ﹤0.01% of Mosley Wealth Management's portfolio in Q2 2026, its #416 holding.
  • Mosley Wealth Management first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.